{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T07:07:26Z","timestamp":1785827246635,"version":"3.56.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["U01HL107352"],"award-info":[{"award-number":["U01HL107352"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["U01HL107407"],"award-info":[{"award-number":["U01HL107407"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["U01HL115662"],"award-info":[{"award-number":["U01HL115662"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvascsurg.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular Surgery"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.jvs.2023.05.006","type":"journal-article","created":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T23:17:54Z","timestamp":1684279074000},"page":"711-718.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Baseline modern medical management in the BEST-CLI trial"],"prefix":"10.1016","volume":"78","author":[{"given":"Matthew T.","family":"Menard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3772-5887","authenticated-orcid":false,"given":"Michael R.","family":"Jaff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alik","family":"Farber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Rosenfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Conte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua A.","family":"Beckman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niteesh K.","family":"Choudhry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo C.","family":"Clavijo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas S.","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine R.","family":"Tuttle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taye H.","family":"Hamza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Schanzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor A.","family":"Laskowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Cziraky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Drooz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"van Over","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9144-6806","authenticated-orcid":false,"given":"Michael B.","family":"Strong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ido","family":"Weinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvs.2023.05.006_bib1","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1161\/CIRCRESAHA.121.318535","article-title":"Epidemiology of peripheral artery disease and polyvascular disease","volume":"128","author":"Aday","year":"2021","journal-title":"Circ Res"},{"issue":"3 Suppl","key":"10.1016\/j.jvs.2023.05.006_bib2","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1016\/j.jvs.2014.12.009","article-title":"Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication","volume":"61","author":"Conte","year":"2015","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2023.05.006_bib3","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","volume":"39","author":"Aboyans","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jvs.2023.05.006_bib4","first-page":"560","article-title":"Canadian cardiovascular society 2022 guidelines for peripheral arterial disease","volume":"38","author":"Abramson","year":"2022","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jvs.2023.05.006_bib5","first-page":"e726","article-title":"2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of cardiology\/American heart association Task Force on clinical practice guidelines","volume":"135","author":"Gerhard-Herman","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2023.05.006_bib6","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/j.jvs.2019.02.016","article-title":"Global vascular guidelines on the management of chronic limb-threatening ischemia","volume":"69","author":"Conte","year":"2019","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2023.05.006_bib7","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1161\/CIRCRESAHA.121.318258","article-title":"Contemporary medical management of peripheral artery disease","volume":"128","author":"Bonaca","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.jvs.2023.05.006_bib8","article-title":"Adherence to guideline-recommended therapy is associated with decreased major adverse cardiovascular events and major adverse limb events among patients with peripheral arterial disease","volume":"3","author":"Armstrong","year":"2014","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jvs.2023.05.006_bib9","article-title":"Design and rationale of the best endovascular versus best surgical therapy for patients with critical limb ischemia (BEST-CLI) trial","volume":"5","author":"Menard","year":"2016","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jvs.2023.05.006_bib10","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jvs.2018.05.255","article-title":"The BEST-CLI trial is nearing the finish line and promises to be worth the wait","volume":"69","author":"Farber","year":"2019","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2023.05.006_bib11","first-page":"e278","article-title":"2014 ACC\/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of cardiology\/American heart association Task Force on practice guidelines","volume":"130","author":"Fleisher","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2023.05.006_bib12","article-title":"Adherance to guideline-recommended therapy \u2013 including supervised exercise therapy referral \u2013 across peripheral artery disease specialty clinics: insights from the international PORTRAIT registry","volume":"9","author":"Saxon","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jvs.2023.05.006_bib13","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/eurheartj\/ehv006","article-title":"Peripheral arterial disease and critical limb ischaemia: still poor outcomes and lack of guideline adherence","volume":"36","author":"Reinecke","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jvs.2023.05.006_bib14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1161\/CIRCULATIONAHA.110.003954","article-title":"Secondary prevention and mortality in peripheral artery disease: national health and nutrition examination study, 1999 to 2004","volume":"124","author":"Pande","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2023.05.006_bib15","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.amjcard.2016.12.023","article-title":"Long-term comparative outcomes of patients with peripheral artery disease with and without concomitant coronary artery disease","volume":"119","author":"Chen","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jvs.2023.05.006_bib16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1611688","article-title":"Ticagrelor versus clopidogrel in symptomatic peripheral artery disease","volume":"376","author":"Hiatt","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2023.05.006_bib17","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1177\/1358863X20987612","article-title":"Medical therapy for cardiovascular and limb-related risk reduction in critical limb ischemia","volume":"26","author":"Giannopoulos","year":"2021","journal-title":"Vasc Med"},{"key":"10.1016\/j.jvs.2023.05.006_bib18","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1177\/1358863X19894055","article-title":"Statin therapy for reduction of cardiovascular and limb-related events in critical limb ischemia: a systematic review and meta-analysis","volume":"25","author":"Kokkinidis","year":"2020","journal-title":"Vasc Med"},{"key":"10.1016\/j.jvs.2023.05.006_bib19","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0140-6736(14)61468-9","article-title":"Hypertension","volume":"386","author":"Poulter","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jvs.2023.05.006_bib20","article-title":"Treatment of hypertension in peripheral arterial disease","author":"Lip","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jvs.2023.05.006_bib21","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1097\/HJH.0000000000002453","article-title":"2020 International Society of Hypertension global hypertension practice guidelines","volume":"38","author":"Unger","year":"2020","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.jvs.2023.05.006_bib22","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1097\/HJH.0000000000001940","volume":"36","author":"Williams","year":"2018","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.jvs.2023.05.006_bib23","first-page":"e13","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.jvs.2023.05.006_bib24","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1161\/ATVBAHA.119.312142","article-title":"Evidence-based medical management of peripheral artery disease","volume":"40","author":"Bevan","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jvs.2023.05.006_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.947645","article-title":"Understanding study drug discontinuation through EUCLID","volume":"9","author":"Weissler","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jvs.2023.05.006_bib26","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/bmj.308.6922.159","article-title":"Collaborative overview of randomised trials of antiplatelet therapy--II: Maintenance of vascular graft or arterial patency by antiplatelet therapy. Antiplatelet Trialists' Collaboration","volume":"308","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/j.jvs.2023.05.006_bib27","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jvs.2003.08.030","article-title":"Patients undergoing infrainguinal bypass to treat atherosclerotic vascular disease are underprescribed cardioprotective medications: effect on graft patency, limb salvage, and mortality","volume":"39","author":"Henke","year":"2004","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2023.05.006_bib28","first-page":"CD000535","article-title":"Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery","volume":"2015","author":"Bedenis","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jvs.2023.05.006_bib29","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without Aspirin in stable cardiovascular disease","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2023.05.006_bib30","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa2000052","article-title":"Rivaroxaban in peripheral artery disease after revascularization","volume":"382","author":"Bonaca","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2023.05.006_bib31","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1161\/ATVBAHA.120.314595","article-title":"Epidemiology and risk of amputation in patients with diabetes mellitus and peripheral artery disease","volume":"40","author":"Barnes","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"Suppl 1","key":"10.1016\/j.jvs.2023.05.006_bib32","first-page":"S55","article-title":"6. Glycemic targets: standards of medical care in diabetes-2018","volume":"41","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jvs.2023.05.006_bib33","doi-asserted-by":"crossref","first-page":"m4573","DOI":"10.1136\/bmj.m4573","article-title":"Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials","volume":"372","author":"Palmer","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jvs.2023.05.006_bib34","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.2337\/dc18-1094","article-title":"The impact of liraglutide on diabetes-related foot ulceration and associated complications in patients with type 2 diabetes at high risk for cardiovascular events: results from the LEADER trial","volume":"41","author":"Dhatariya","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jvs.2023.05.006_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.109076","article-title":"Major adverse limb events in type 2 diabetes patients receiving glucagon-like peptide-1 receptor agonists versus sodium-glucose cotransporter 2 inhibitors: a retrospective multi-institutional study","volume":"180","author":"Hsiao","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jvs.2023.05.006_bib36","article-title":"National Trends in use of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists by cardiologists and other specialties, 2015 to 2020","volume":"11","author":"Adhikari","year":"2022","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jvs.2023.05.006_bib37","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jvs.2021.07.248","article-title":"A\u00a0meta-analysis of randomized controlled trials evaluating the efficacy of smoking cessation interventions in people with peripheral artery disease","volume":"75","author":"Thanigaimani","year":"2022","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2023.05.006_bib38","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1161\/01.CIR.0000132612.07145.25","article-title":"Concomitant peripheral arterial disease and coronary artery disease: therapeutic opportunities","volume":"109","author":"Bittle","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2023.05.006_bib39","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1016\/j.jacc.2021.04.060","article-title":"Effectiveness of blood lipid management in patients with peripheral artery disease","volume":"77","author":"Hess","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2023.05.006_bib40","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1161\/CIRCRESAHA.121.318243","article-title":"Racial and ethnic disparities in peripheral artery disease","volume":"128","author":"Hackler","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.jvs.2023.05.006_bib42","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/gerona\/glaa264","article-title":"Black-white disparities in social and Behavioral determinants of health index and their Associations with self-rated health and Functional limitations in older Adults","volume":"76","author":"Greg Rhee","year":"2021","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"}],"container-title":["Journal of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521423011771?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521423011771?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T20:41:49Z","timestamp":1760042509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0741521423011771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0741521423011771"],"URL":"https:\/\/doi.org\/10.1016\/j.jvs.2023.05.006","relation":{},"ISSN":["0741-5214"],"issn-type":[{"value":"0741-5214","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Baseline modern medical management in the BEST-CLI trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvs.2023.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the Society for Vascular Surgery. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}